Huntington’s disease poses a threat to the brain—the core governing system of sensation, intellectual ability, nerve-related ...

After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...

Huntington's Disease is one of the most devastating diseases out there and many people have never heard of it. Actor WIll ...

Sage Therapeutics discontinued development of its lead candidate dalzanemdor after a third clinical failure, leading analysts ...

Huntington's Disease is one of the most devastating diseases out there and many people have never heard of it. Actor WIll ...

After previously failing studies in Parkinson’s and Alzheimer’s, dalzanemdor’s latest stumble in Huntington’s disease has ...

Scientists at La Trobe University have created a world-first method to investigate "disordered" proteins in living cells, in ...

The Huntington's disease (HD) mutation eventually causes a fatal brain disease in adulthood, but a new study finds that early in life, children with the HD mutation have bigger brains and higher IQ ...

Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for cognitive ...

Alzheimer’s and Huntington’s patients do have different symptoms and disease biology, but that made no difference to the ...

It was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as ...

The Phase II DIMENSION study of Sage's dalzanemdor failed to meet its primary and secondary endpoints for treating Huntington ...